May Health
A medical device company developing a minimally invasive ablation technology designed to restore ovulation in women with PCOS-related infertility.
- sustainable development goals
- dt and ls
- radar de l'innovation
- tech for business
- observatoire industrial tech
- observatoire deeptech
- tech for patients
- digital care
- biotech, medtech and e-health
- non-invasive medical devices and treatments
- femtech
- observatoire healthtech
- participations bpifrance
- fertility
- reproductive health
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | $25.0m | Series B | |
| Total Funding | 000k | ||
| EUR | 2019 | 2020 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | (99 %) |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
May Health operates in the healthcare sector, focusing on developing innovative treatments for Polycystic Ovary Syndrome (PCOS). The company aims to address the needs of both patients and healthcare professionals by providing a novel solution designed to restore ovulation through targeted ovarian ablation. This one-time treatment aims to lower androgen production, which can often restore ovulation, offering a modern approach to managing PCOS. May Health's business model revolves around extensive research and clinical trials, ensuring their devices meet safety and efficacy standards set by regulatory bodies like the FDA and European Competent Authorities. The company generates revenue through the development and eventual commercialization of its medical devices, targeting a niche but significant market of individuals affected by PCOS. By focusing on both the clinical and informational aspects of PCOS treatment, May Health aims to empower patients and physicians with the knowledge and tools necessary for effective management of the condition.
Keywords: PCOS, ovarian ablation, ovulation restoration, healthcare, clinical trials, FDA approval, androgen reduction, medical devices, patient empowerment, physician support.